Every 8-K that Alpha Teknova, Inc. (TKNO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow TKNO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TKNO filings page.
Alpha Teknova reported Q2 2026 revenue of $12.2 million, up 18% from $10.3 million a year earlier, with growth across Lab Essentials and Clinical Solutions. Gross profit rose to $4.9 million and gross margin improved to 40.1% from 38.7%.
Net loss narrowed to $3.2 million, or $0.06 per share, versus $3.6 million, or $0.07 per share. Adjusted EBITDA was a loss of $0.7 million. Free Cash Outflow improved to $0.6 million from $2.3 million, as cash used in operating activities declined to $0.5 million.
Total cash and short-term investments were $17.4 million and total borrowings were $13.2 million at June 30, 2026. Management raised 2026 revenue guidance to $45–$47 million, now expecting Free Cash Outflow of less than $8 million, and launched its AI-powered Build-Tek custom configurator.
Alpha Teknova, Inc. reported governance updates and voting results from its 2026 Annual Meeting of Stockholders. Director Irene Davis chose not to stand for re-election and retired from the Board and its Nominating and Corporate Governance Committee for personal and professional reasons, with no disagreement related to company matters.
Effective June 1, 2026, the Board reduced its size from eight to seven directors and decreased the number of Class II directors from three to two, and appointed existing director Ms. Demski to the Nominating and Corporate Governance Committee. At the meeting, 47,821,520 shares, representing 89.20% of common stock outstanding as of the record date, were represented.
Stockholders elected Class II directors J. Matthew Mackowski and Brett Robertson to serve until the 2029 annual meeting and ratified Grant Thornton LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Alpha Teknova reported first quarter 2026 revenue of $11.1 million, up 13% from $9.8 million a year earlier, driven by growth in both major product lines. Lab Essentials revenue rose to $8.4 million, while Clinical Solutions nearly doubled to $2.1 million.
Gross margin improved to 34.2% from 30.7% as gross profit increased to $3.8 million. Operating expenses were $8.1 million, resulting in a net loss of $4.6 million, or $0.08 per share, similar to the prior year. Adjusted EBITDA was negative $2.0 million and Free Cash Outflow was $3.6 million, both better than 2025 levels.
The company ended the quarter with $17.8 million in cash and short-term investments and $13.2 million of total borrowings. Teknova reaffirmed its 2026 outlook for revenue of $42–44 million and expects full-year Free Cash Outflow of less than $10 million. The board also approved a refreshed Code of Business Conduct and Ethics focused on updates, clarifications, and administrative improvements.
Alpha Teknova, Inc. reported moderate growth and much stronger margins for 2025 while remaining unprofitable. Total revenue for 2025 was $40.5 million, up 7% from $37.7 million, with fourth-quarter revenue of $10.0 million, up 8% year over year.
Full-year gross margin improved to 33.2% from 19.2%, helped by higher revenue and manufacturing efficiency gains, and operating expenses fell to $30.4 million from $33.4 million. Net loss narrowed to $17.3 million (negative $0.32 per share) from $26.7 million, and Adjusted EBITDA improved to negative $6.7 million from negative $14.5 million.
Free Cash Flow for 2025 was negative $9.8 million, better than negative $13.5 million in 2024 and ahead of the company’s prior target. Teknova ended 2025 with $21.3 million in cash and short-term investments and $13.2 million of gross debt, and guided 2026 revenue to $42–44 million with expected Free Cash Outflow of less than $10 million.
Alpha Teknova (TKNO) furnished Q3 results. The company reported that it issued a press release announcing financial results for the quarter ended September 30, 2025. The release was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01, with the full text included as Exhibit 99.1.
The materials are designated as furnished, not filed, under the Exchange Act.
Alpha Teknova, Inc. (Nasdaq: TKNO) filed a Form 8-K reporting the results of its 2025 Annual Meeting of Stockholders held on June 17, 2025. A strong quorum of 88.62% of outstanding shares (47,356,521) was present in person or by proxy.
Proposal 1 – Election of Class I Directors: Martha J. Demski and Alexander Herzick were elected to serve until the 2028 Annual Meeting. Each received more than 42.5 million “for” votes, with fewer than 1 million votes withheld and 4.0 million broker non-votes.
Proposal 2 – Auditor Ratification: Grant Thornton LLP was ratified as independent auditor for fiscal 2025 with 47,336,767 “for” votes, representing virtually unanimous support (99.96% of votes cast).
No other matters were brought before shareholders, and the filing contained no financial performance updates or strategic disclosures. These results reflect routine corporate-governance actions with broad shareholder endorsement.